Serono SA
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.985 ISSN: 1756-7874
Section: Company Profile
Fulltext:
Abstract
Serono, third largest biotech company, focuses on the discovery, development and marketing of recombinant proteins and small molecules in the fields of reproductive health for treating infertility, neurology for treating relapse of multiple sclerosis, metabolic endocrinology for treating HIV-associated wasting and growth deficiencies, autoimmune diseases, oncology, gastroenterology and rheumatology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS